ArticleNPJ vaccines2022

A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine.

Jenny G Low et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.